Krishna Institute of Medical Sciences Limited

NSE KIMS.NS

Krishna Institute of Medical Sciences Limited Price to Sales Ratio (P/S) on January 14, 2025: 9.49

Krishna Institute of Medical Sciences Limited Price to Sales Ratio (P/S) is 9.49 on January 14, 2025, a 34.06% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Krishna Institute of Medical Sciences Limited 52-week high Price to Sales Ratio (P/S) is 10.72 on January 07, 2025, which is 13.05% above the current Price to Sales Ratio (P/S).
Krishna Institute of Medical Sciences Limited 52-week low Price to Sales Ratio (P/S) is 5.83 on May 29, 2024, which is -38.53% below the current Price to Sales Ratio (P/S).
Krishna Institute of Medical Sciences Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 7.73.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: KIMS.NS

Krishna Institute of Medical Sciences Limited

CEO	Dr. Abhinay Bollineni
IPO Date	June 28, 2021
Location	India
Headquarters	D. No. 1-8-31/1
Employees	5,013
Sector	Health Care
Industries Medical Instruments Hospitals & Clinics Pharmaceuticals

Description

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It also focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, alzheimers, bone, joint center specialties, and others. The company was incorporated in 1973 and is based in Secunderabad, India.

Key trends

Past 5 years